Skip to main content
Erschienen in: European Journal of Pediatrics 11/2023

30.08.2023 | RESEARCH

New predictive models and indices for screening MAFLD in school-aged overweight/obese children

verfasst von: Yunfei Xing, PingPing Zhang, Xueying Li, Shifeng Jin, Miao Xu, Jinzhu Jia, Hai-Jun Wang, Li Li, Hui Wang

Erschienen in: European Journal of Pediatrics | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

Currently, most predictions of metabolic-associated fatty liver disease (MAFLD) in school-aged children utilize indicators that usually predict nonalcoholic fatty liver disease (NAFLD). The present study aimed to develop new predictive models and predictors for children with MAFLD, which could enhance the feasibility of MAFLD screening programs in the future. A total of 331 school-aged overweight/obese children were recruited from six primary schools in Ningbo city, China. Hepatic steatosis and fibrosis were detected with controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), respectively. Machine learning methods were adapted to build a set of variables to predict MAFLD in children. Then, the area under the curve (AUC) of multiple models and indices was compared to predict pediatric MAFLD. Compared with non-MAFLD children, children with MAFLD had more obvious metabolic disturbances, as they had higher anthropometric indicators, alanine aminotransferase, fasting plasma glucose, and inflammation indicators (white blood cell count, hemoglobin, neutrophil count) (all P < 0.05). The optimal variables for all subjects selected by random forest (RF) were alanine aminotransferase, uric acid, insulin, and BMI. The logistic regression (LR) model performed best, with AUC values of 0.758 for males and 0.642 for females in predicting MAFLD. LnAI-BMI, LnAI, and LnAL-WHtR were approving indices for predicting pediatric MAFLD in all participants, boys and girls individually.
Conclusions: This study developed LR models and sex-specific indices for predicting MAFLD in overweight/obese children that may be useful for widespread screening and identification of children at high risk of MAFLD for early treatment.
What is Known:
• Most of the indicators predicting pediatric MAFLD are derived from the predictive indicators for NAFLD, but the diagnostic criteria for MAFLD and NAFLD are not exactly the same.
• The accuracy of predictors based on routine physical examination and blood biochemical indicators to diagnose MAFLD is limited.
What is New:
• This study developed indicators based on routine examination parameters that have approving performance for MAFLD, with AUC values exceeding 0.70.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Manco M (2017) Insulin resistance and NAFLD: a dangerous liaison beyond the genetics. Children-Basel 4(8) Manco M (2017) Insulin resistance and NAFLD: a dangerous liaison beyond the genetics. Children-Basel 4(8)
2.
Zurück zum Zitat Song K, Park G, Lee HS, Lee M, Lee HI, Ahn J, Lee E, Choi HS, Suh J, Kwon A, Kim HS, Chae HW (2022) Trends in prediabetes and non-alcoholic fatty liver disease associated with abdominal obesity among Korean children and adolescents: based on the Korea National Health and Nutrition Examination Survey between 2009 and 2018. Biomedicines 10(3) Song K, Park G, Lee HS, Lee M, Lee HI, Ahn J, Lee E, Choi HS, Suh J, Kwon A, Kim HS, Chae HW (2022) Trends in prediabetes and non-alcoholic fatty liver disease associated with abdominal obesity among Korean children and adolescents: based on the Korea National Health and Nutrition Examination Survey between 2009 and 2018. Biomedicines 10(3)
3.
Zurück zum Zitat Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA (2022) The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 7(9):851–861CrossRefPubMed Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA (2022) The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 7(9):851–861CrossRefPubMed
4.
Zurück zum Zitat Dietrich P, Hellerbrand C (2014) Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Cl Ga 28:637–653CrossRef Dietrich P, Hellerbrand C (2014) Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Cl Ga 28:637–653CrossRef
5.
Zurück zum Zitat Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S et al (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73:202–209CrossRefPubMed Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S et al (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73:202–209CrossRefPubMed
6.
Zurück zum Zitat Eslam M, Alkhouri N, Vajro P, Baumann U, Weiss R, Socha P, Marcus C, Lee WS, Kelly D, Porta G, El-Guindi MA, Alisi A, Mann JP, Mouane N, Baur LA, Dhawan A, George J (2021) Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. Lancet Gastroenterol 6:864–873 Eslam M, Alkhouri N, Vajro P, Baumann U, Weiss R, Socha P, Marcus C, Lee WS, Kelly D, Porta G, El-Guindi MA, Alisi A, Mann JP, Mouane N, Baur LA, Dhawan A, George J (2021) Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. Lancet Gastroenterol 6:864–873
7.
Zurück zum Zitat Tilg H, Effenberger M (2020) From NAFLD to MAFLD: when pathophysiology succeeds. Nat Rev Gastro Hepat 17:387–388CrossRef Tilg H, Effenberger M (2020) From NAFLD to MAFLD: when pathophysiology succeeds. Nat Rev Gastro Hepat 17:387–388CrossRef
8.
Zurück zum Zitat Shiha G, Korenjak M, Eskridge W, Casanovas T, Velez-Moller P, Hogstrom S, Richardson B et al (2021) Redefining fatty liver disease: an international patient perspective. Lancet Gastroenterol Hepatol 6:73–79CrossRefPubMed Shiha G, Korenjak M, Eskridge W, Casanovas T, Velez-Moller P, Hogstrom S, Richardson B et al (2021) Redefining fatty liver disease: an international patient perspective. Lancet Gastroenterol Hepatol 6:73–79CrossRefPubMed
9.
Zurück zum Zitat Ciardullo S, Monti T, Perseghin G (2021) Prevalence of liver steatosis and fibrosis detected by transient elastography in adolescents in the 2017–2018 National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol 19:384–390CrossRefPubMed Ciardullo S, Monti T, Perseghin G (2021) Prevalence of liver steatosis and fibrosis detected by transient elastography in adolescents in the 2017–2018 National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol 19:384–390CrossRefPubMed
10.
Zurück zum Zitat Cholongitas E, Pavlopoulou I, Papatheodoridi M, Markakis GE, Bouras E, Haidich AB, Papatheodoridis G (2021) Epidemiology of nonalcoholic fatty liver disease in Europe: a systematic review and meta-analysis. Ann Gastroenterol 34:404–414PubMedPubMedCentral Cholongitas E, Pavlopoulou I, Papatheodoridi M, Markakis GE, Bouras E, Haidich AB, Papatheodoridis G (2021) Epidemiology of nonalcoholic fatty liver disease in Europe: a systematic review and meta-analysis. Ann Gastroenterol 34:404–414PubMedPubMedCentral
11.
Zurück zum Zitat Song K, Park G, Lee HS, Lee M, Lee HI, Choi HS, Suh J, Kwon A, Kim HS, Chae HW (2022) Comparison of the triglyceride glucose index and modified triglyceride glucose indices to predict nonalcoholic fatty liver disease in youths. J Pediatr 242(79–85):e71 Song K, Park G, Lee HS, Lee M, Lee HI, Choi HS, Suh J, Kwon A, Kim HS, Chae HW (2022) Comparison of the triglyceride glucose index and modified triglyceride glucose indices to predict nonalcoholic fatty liver disease in youths. J Pediatr 242(79–85):e71
12.
Zurück zum Zitat Nobili V, Alisi A, Vania A, Tiribelli C, Pietrobattista A, Bedogni G (2009) The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease. BMC Med 7:21CrossRefPubMedPubMedCentral Nobili V, Alisi A, Vania A, Tiribelli C, Pietrobattista A, Bedogni G (2009) The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease. BMC Med 7:21CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Xing Y, Fan J, Wang HJ, Wang H (2023) Comparison of MAFLD and NAFLD characteristics in children. Children (Basel) 10 Xing Y, Fan J, Wang HJ, Wang H (2023) Comparison of MAFLD and NAFLD characteristics in children. Children (Basel) 10
14.
Zurück zum Zitat Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de Ledinghen V, Kumar M et al (2017) Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol 66:1022–1030CrossRefPubMed Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de Ledinghen V, Kumar M et al (2017) Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol 66:1022–1030CrossRefPubMed
15.
Zurück zum Zitat Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, Fruhwirth R, Marcellini M, Pinzani M (2008) Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 48:442–448CrossRefPubMed Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, Fruhwirth R, Marcellini M, Pinzani M (2008) Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 48:442–448CrossRefPubMed
17.
Zurück zum Zitat Subspecialty of Endocrinology, Genetics and Metabolism, Society of Pediatrics, Chinese Medical Association (2017) China expert consensus of diagnosis and treatment of children and adolescents with type 2 diabetes. Chin J Pediatrics 55:404–410 Subspecialty of Endocrinology, Genetics and Metabolism, Society of Pediatrics, Chinese Medical Association (2017) China expert consensus of diagnosis and treatment of children and adolescents with type 2 diabetes. Chin J Pediatrics 55:404–410
20.
Zurück zum Zitat Xiao P, Cheng H, Hou D, Gao A, Wang L, Yu Z, Wang H, Zhao X, Li H, Huang G, Mi J (2020) A comparative study on the diagnostic cut-points of dyslipidemia in Chinese children and adolescents. Chin J Epidemiol 41:62–67 Xiao P, Cheng H, Hou D, Gao A, Wang L, Yu Z, Wang H, Zhao X, Li H, Huang G, Mi J (2020) A comparative study on the diagnostic cut-points of dyslipidemia in Chinese children and adolescents. Chin J Epidemiol 41:62–67
21.
Zurück zum Zitat Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6:299–304CrossRefPubMed Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6:299–304CrossRefPubMed
22.
Zurück zum Zitat Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, Guha IN, Cobbold JF, Deeks JJ, Paradis V, Bedossa P, Newsome PN (2019) Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 156:1717–1730CrossRefPubMed Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, Guha IN, Cobbold JF, Deeks JJ, Paradis V, Bedossa P, Newsome PN (2019) Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 156:1717–1730CrossRefPubMed
23.
Zurück zum Zitat Uddin S, Khan A, Hossain ME, Moni MA (2019) Comparing different supervised machine learning algorithms for disease prediction. BMC Med Inform Decis Mak 19:281CrossRefPubMedPubMedCentral Uddin S, Khan A, Hossain ME, Moni MA (2019) Comparing different supervised machine learning algorithms for disease prediction. BMC Med Inform Decis Mak 19:281CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Ruhl CE, Everhart JE (2003) Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124:71–79CrossRefPubMed Ruhl CE, Everhart JE (2003) Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124:71–79CrossRefPubMed
26.
Zurück zum Zitat Manco M, Alisi A, Nobili V (2008) Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric report. Hepatology 48:2087–2088CrossRefPubMed Manco M, Alisi A, Nobili V (2008) Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric report. Hepatology 48:2087–2088CrossRefPubMed
27.
Zurück zum Zitat Ma XF, Liu SH, Zhang J, Dong MZ, Wang YF, Wang MK, Xin YN (2020) Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis. BMC Gastroenterology 20 Ma XF, Liu SH, Zhang J, Dong MZ, Wang YF, Wang MK, Xin YN (2020) Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis. BMC Gastroenterology 20
28.
Zurück zum Zitat Vergani L (2019) Fatty acids and effects on in vitro and in vivo models of liver steatosis. Curr Med Chem 26:3439–3456CrossRefPubMed Vergani L (2019) Fatty acids and effects on in vitro and in vivo models of liver steatosis. Curr Med Chem 26:3439–3456CrossRefPubMed
29.
Zurück zum Zitat Mato JM, Alonso C, Noureddin M, Lu SC (2019) Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. World J Gastroenterol 25:3009–3020CrossRefPubMedPubMedCentral Mato JM, Alonso C, Noureddin M, Lu SC (2019) Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. World J Gastroenterol 25:3009–3020CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Brown MS, Goldstein JL (2008) Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 7:95–96CrossRefPubMed Brown MS, Goldstein JL (2008) Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 7:95–96CrossRefPubMed
32.
Zurück zum Zitat Matsuda M, Shimomura I (2013) Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract 7:e330-341CrossRefPubMed Matsuda M, Shimomura I (2013) Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract 7:e330-341CrossRefPubMed
33.
Zurück zum Zitat Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, Lopez-Jimenez F (2010) Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obesity 34:791–799CrossRef Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, Lopez-Jimenez F (2010) Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obesity 34:791–799CrossRef
34.
Zurück zum Zitat Singh A, Parida S, Narayan J, Nath P, Padhi PK, Pati GK, Parida PK, Meher C, Agrawal O, Singh SP (2017) Simple anthropometric indices are useful for predicting non-alcoholic fatty liver disease [NAFLD] in Asian Indians. J Clin Exp Hepatol 7:310–315CrossRefPubMedPubMedCentral Singh A, Parida S, Narayan J, Nath P, Padhi PK, Pati GK, Parida PK, Meher C, Agrawal O, Singh SP (2017) Simple anthropometric indices are useful for predicting non-alcoholic fatty liver disease [NAFLD] in Asian Indians. J Clin Exp Hepatol 7:310–315CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Song K, Lee HW, Choi HS, Park G, Lee HS, Kim SJ, Lee M, Suh J, Kwon A, Kim HS (2022) Comparison of the modified TyG indices and other parameters to predict non-alcoholic fatty liver disease in youth. Biology (Basel) 11 Song K, Lee HW, Choi HS, Park G, Lee HS, Kim SJ, Lee M, Suh J, Kwon A, Kim HS (2022) Comparison of the modified TyG indices and other parameters to predict non-alcoholic fatty liver disease in youth. Biology (Basel) 11
36.
Zurück zum Zitat Engl J, Sturm W, Sandhofer A, Kaser S, Tschoner A, Tatarczyk T, Weiss H, Tilg H, Patsch JR, Ebenbichler CF (2008) Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms. Eur J Clin Invest 38:238–244CrossRefPubMed Engl J, Sturm W, Sandhofer A, Kaser S, Tschoner A, Tatarczyk T, Weiss H, Tilg H, Patsch JR, Ebenbichler CF (2008) Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms. Eur J Clin Invest 38:238–244CrossRefPubMed
37.
Zurück zum Zitat Zheng S, Shi S, Ren X, Han T, Li Y, Chen Y, Liu W, Hou PC, Hu Y (2016) Triglyceride glucose-waist circumference, a novel and effective predictor of diabetes in first-degree relatives of type 2 diabetes patients: cross-sectional and prospective cohort study. J Transl Med 14:260CrossRefPubMedPubMedCentral Zheng S, Shi S, Ren X, Han T, Li Y, Chen Y, Liu W, Hou PC, Hu Y (2016) Triglyceride glucose-waist circumference, a novel and effective predictor of diabetes in first-degree relatives of type 2 diabetes patients: cross-sectional and prospective cohort study. J Transl Med 14:260CrossRefPubMedPubMedCentral
Metadaten
Titel
New predictive models and indices for screening MAFLD in school-aged overweight/obese children
verfasst von
Yunfei Xing
PingPing Zhang
Xueying Li
Shifeng Jin
Miao Xu
Jinzhu Jia
Hai-Jun Wang
Li Li
Hui Wang
Publikationsdatum
30.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 11/2023
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-023-05175-x

Weitere Artikel der Ausgabe 11/2023

European Journal of Pediatrics 11/2023 Zur Ausgabe

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Häufigste Gründe für Brustschmerzen bei Kindern

06.05.2024 Pädiatrische Diagnostik Nachrichten

Akute Brustschmerzen sind ein Alarmsymptom par exellence, schließlich sind manche Auslöser lebensbedrohlich. Auch Kinder klagen oft über Schmerzen in der Brust. Ein Studienteam ist den Ursachen nachgegangen.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Durch übermäßige Internetnutzung wird oft die Schule verpasst

Häufige Fehlzeiten in der Schule können durch physische und psychische Probleme verursacht werden. Wie in einer Studie aus Finnland nun belegt wird, führt auch die exzessive Nutzung des Internets gehäuft zu Abwesenheiten.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.